The leading cloud-based patient engagement and adherence platform for the life sciences adds management depth in response to significant growth
Focusing on specific KPIs for adherence programs can help pharma not only impact patient outcomes, but also build better return-on-investment models and adherence-targeted revenue strategies.
Enrolled users experience average adherence lifts of 52 percent over baseline, promoted and prompted by frequent engagement over long periods of time
HealthPrize CEO Tom Kottler recently spoke with Jill Malandrino, host of Nasdaq’s Trade Talks, about why pharma should look to medication adherence as its new profit source.
Pharma’s continued dependence on tactics such as raising drug prices to hit profit targets just aren’t sustainable long-term. Further, price increases – responsible for 100 percent of pharma’s 2016 earnings per share (EPS) growth – do not improve patient outcomes or save lives.
Boehringer Ingelheim and HealthPrize Technologies today announced the expansion of the RespiPoints digital support program to anyone taking one of several Boehringer Ingelheim medicines, including select medicines available in the Respimat inhaler.
The digital adherence and patient engagement platform is recognized by Frost for improving patient outcomes and solving business challenges.
The two companies extend their collaboration to integrate West’s drug delivery systems with HealthPrize’s digital adherence and engagement platform.
We’re packing our bags – and our booth shwag – and getting ready for the Spring season of life science marketing conferences. If you’d like to learn more about HealthPrize, we’d like to learn more about your challenges and goals.
Medication non-adherence is one of the most serious problems in healthcare, posing a heavy financial impact on all constituencies.